SEED Therapeutics, Inc.
1 clinical trials · Sponsor
◉ Watch SEED Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies (NCT07197554) | SEED Therapeutics, Inc. | 2025-12-01 |
Track SEED Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.